Sign up


Match Document Document Title
7414038 Embolic materials  
The object of the present invention is to provide an embolizing material which is easily handleable and stable in quality and is solved by providing an embolizing material comprising an ester...
7414021 Method and composition for restoration of age related tissue loss in the face or selected areas of the body  
A treatment method for restoring of age related tissue loss in the face or selected areas of the body is disclosed which includes injecting an injectable composition containing a growth factor and...
7407779 Modification of solid 3-sn-phosphoglycerides  
Methods for hydrolyzing solid ungranulated lysophosphatidylcholine with phospholipase A2 are provided. Also disclosed are methods for making a lipid matrix of lysophosphatidylcholine, monoglyceride...
7407945 Use of sulfated glycosaminoglycans for establishing effective labor in women  
The invention refers to the use of sulfated glycosaminoglycans having an anticoagulant activity of 100 BP units/mg or less for the manufacture of a pharmaceutical preparation for prophylactic...
7393841 Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander  
The invention relates to the use of hyperbranched amylopectin which has an average branch degree of between >10 and 25 mol % and a molecular weight (Mw) ranging from 40.000-800.000 Dalton and the...
7375095 Sugar derivative  
For extending the uses of a compound represented by Chemical formula 1, the object of the present invention is to provide a derivative of cyclic tetrasaccharide whose physicochemical properties are...
7375089 Rehydration composition  
The invention relates to a fluid that can be used for preventing or treating hypohydration and the secondary consequences thereof. The fluid comprises one or more carbohydrates and minerals and is...
7371738 Method of transdermal drug delivery using hyaluronic acid nanoparticles  
The present invention relates to the development of a hyaluronic acid and hyaluronic acid hybrid nanoparticle systems for the administration of active molecules, peptides, DNA and/or other...
7365059 Photocrosslinked-polysaccharide composition and production process of the same  
A process for producing a photocrosslinked-polysaccharide composition, which comprises: freezing a photoreactive polysaccharide-containing solution comprising a photoreactive polysaccharide in...
7361644 Specific antagonist for both E- and P-selectins  
Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the...
7354910 Agent for treating inflammatory bowel diseases  
An agent for treating inflammatory bowel diseases and an agent for preventing or improving symptoms accompanied by inflammatory bowel diseases, which each comprises hyaluronic acid or a...
7354600 Muco-adhesive polymers, use thereof and method for producing the same  
Mucoadhesive polymers, the use thereof and a production method therefor. Mucoadhesive polymers assembled of not more than 10 different monomers and comprising at least one non-terminal thiol group,...
7351741 Compounds and compositions for delivering active agents  
Compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provide as well.
7348021 Immunostimulating coating for surgical devices  
The present invention discloses an immunostimulating agent that may be applied to various surgical devices to promote rapid healing and the ready acceptance and integration of the surgical devices...
7345117 Sulphated hyaluronic acid and sulphated derivatives thereof covalently bound to polyurethanes, and the process for their preparation  
The present invention relates to the synthesis of a haemocompatible polymer, consisting of a polyurethane bound covalently to sulphated hyaluronic acid. These sulfated derivatives have...
7341981 Spray composition having a deposition control agent  
A spray composition includes an aqueous spray medium, an active ingredient, and a deposition control agent, wherein: the composition comprises at least one surfactant, andthe deposition control...
7338943 Hyaluronic acid in soft gel form  
An orally administered soft gelatin formulation preparation of low molecular weight Hyaluronic Acid (HA) for use as a nutritional supplement to provide the primary benefit of internally causing the...
7338942 Composition and method for maintaining healthy mobile joints and cartilage  
Compositions and methods for maintaining healthy mobile joints and cartilage in humans and animals are disclosed. The composition comprises glucosamine and chondroitin dispersed in a...
7335384 Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith  
The present disclosure describes a novel composition for the treatment and/or prevention of neurogenic inflammation. Such composition is also useful in the treatment and/or prevention of disease...
7332323 Strain of Sphingomonas pituitosa and method of exopolysaccharide production therefrom  
The present invention concerns a new epoxypolysaccharide-producing bacterium, the exopolysaccharide isolated from this bacterium and the use of the exopolysaccharide.
7323540 Process for preparing microrods using liquid-liquid dispersion  
The invention provides a method for forming polymer microrods, the method including the steps of providing a polymer solution comprising a polymer dissolved in a first solvent; providing a...
7322369 Methods of detaching microorganisms from, or of inhibiting microbial attachment to, animal or poultry carcasses or seafood or parts thereof  
Methods of detaching microorganisms (e.g., bacteria) from, or of inhibiting microbial (e.g., bacterial) attachment to, animal or poultry carcasses or seafood or parts thereof, wherein the method...
7323184 Compositions and methods for the treatment of wounds and the reduction of scar formation  
The present invention relates to methods and compositions for inhibiting scar formation on wound region. In certain embodiments, the methods include administering an alkalinization agent in...
7323452 Method for the accelerated in vivo removal of ethanol  
A method for accelerating the process of removing ethanol from the blood through the use of certain additives that accelerate the metabolic oxidation of ethanol, and others which in addition act as...
7323329 Methods for production of hyaluronic acid, and isolated strains of supercapsulated streptococci  
Isolated strains of supercapsulated streptococci band at a density of no greater than 1.03 g/cm3 in a Percoll gradient and are capable of producing hyaluronic acid with molecular weight exceeding 6...
7320962 Hemoactive compositions and methods for their manufacture and use  
Dried hemoactive materials comprise both a cross-linked biologically compatible polymer and a non-cross-linked biologically compatible polymer. The cross-linked polymer is selected to form a...
7312194 Delivery systems  
The invention relates to compounds which are useful in the delivery of a wide variety of therapeutically useful molecules. In particular, the invention relates to compounds which are able to act as...
7309502 Pharmaceutical compositions for treating and saving and the method for the preparation thereof  
The present invention relates to a pharmaceutical composition and the method for the preparation thereof. The composition comprises 1.5˜6.9% (w/v) of one or more substances selected from sodium ...
7309697 Cyclic maltosylmatose  
An object of the present invention is to provide an option of non-reducing saccharide by providing a novel non-reducing saccharide composed of glucose as constituents and to provide a novel enzyme...
7306802 Ophthalmic compositions containing a synergistic combination of three polymers  
Ophthalmic compositions suitable for use as artificial tears or as vehicles for ophthalmic drugs are disclosed. The compositions contain a combination of three polymers that have a synergistic...
7304039 Glucose-based compounds with affinity to P-selectin  
The present invention relates to certain glucose-based compounds that have an affinity to P-selectin. Further, the invention relates to the use of these glucose-based compounds for the preparation...
7297687 Method of treating infectious diseases with polysaccharide derivatives  
The present invention relates to a method of treating infectious diseases, that involves: (a) providing an alpha-glycosidically linked starch polysaccharide derivative; and (b) inhibiting the...
7291607 Isomaltooligosaccharides from Leuconostoc as neutraceuticals  
Isomaltooligosaccharides (IMOs) produced by Leuconostoc mesenteroides ATCC 13146 fermentation with a sucrose:maltose ratio of 2:1 have been discovered to be effective prebiotics in mixed cultures...
7273729 Chondroitin synthase and DNA encoding the enzyme  
A human-derived novel chondroitin synthase, which is an enzyme for synthesizing a fundamental backbone of chondroitin and has both glucuronic acid transferase activity and N-acetylgalactosamine...
7271158 Treatment of rumen acidosis with α-amylase inhibitors  
The invention described herein relates to: the use of an effective inhibitor of a bacterial α-amylase and/or α-glucosidase in the manufacture of a composition for the treatment of acidosis; a m...
7268122 Use of oversulfated polysaccharides as inhibitors of HIV  
The present invention relates to the use of N,O oversulfated K5 derivatives having a degree of sulfation higher than 3.2 or of their pharmaceutically acceptable salts for the preparation of...
7262180 Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye  
The present invention relates to compositions comprising telmesteine, glycyrrhetinic acid, and a proanthocyanidin, as well as methods for using such compositions in the treatment of an inflammatory...
7262179 Wound care compositions  
Compositions for the treatment of wounds and skin injuries are described. The compositions, which include gellan gum, increases in viscosity once applied to the wound to form an immobile gel. The...
RE39789 Tumor therapy  
Neoplasia is treated by administering to a mammalian host a composition comprising ligands for the NKG2D receptor. In addition, other NKG2D ligands, proteins specific for the neoplastic cells and...
7259152 Methods and compositions using sulodexide for the treatment of diabetic nephropathy  
The present invention provides oral formulations of Sulodexide for the treatment of diabetic nephropathy in patients with both insulin dependent and non-insulin dependent diabetes mellitus. Oral...
7259153 Drug formulation and delivery using crystalline methylated cyclodextrins  
The present invention is directed to pharmaceutical compositions containing crystalline methylated cyclodextrins, which enhance the solubility of the pharmaceutically active agent or agents of the...
7256171 Use of core 2 G1cNAc transferase inhibitors in treating inflammation  
This invention provides compounds and methods for treating inflammation. The compounds modulate the core 2 oligosaccharide-mediated binding of inflammatory cells, such as neutrophils, to...
7252828 Polysaccharide vaccine for staphylococcal infections  
The invention relates to compositions of the capsular polysaccharide/adhesin (PS/A) of staphylococci. The PS/A may be isolated or synthesized and includes various modifications to the structure of...
7253152 Electrically conductive polymeric biomaterials, the process for their preparation and the use thereof in the biomedical and healthcare field  
The present invention concerns the preparation of composite biomaterials constituted by hyaluronic acid and the derivatives thereof in combination with polymers that have electrically conductive...
7241735 Pharmacologically active polypeptide glycoconjugates  
The invention relates to glycopeptidic glycoconjugates, in which the polysaccharide is obtained from Candida utilis cells and the peptides are obtained from Ricinus communis seeds. The...
7238677 Prevention of urogenital infections  
The invention provides hyaluronic acid compounds and derivatives thereof for preventing urogenital infections by a variety of pathogens, as well as compositions, articles and methods for treating...
7235251 Cosmetic or dermatological oil/water emulsions with reduced lipid content  
Cosmetic or dermatological preparations comprising (I) one or more surface-active substances chosen from the group (Ia) of alkyl glucosides(Ib) of the disaccharides esterified with one or more...
7229977 Composition for soluble films with a new hydrolyzed polysaccharide  
The invention is concerned with film-forming compositions containing hydrolysates of the exopolysaccharide YAS34 for the use in pharmaceutical, veterinary, food, cosmetic or other products like...
7226914 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections  
A method for treating and preventing various infections, including papilloma virus and fungal and parasitic infections is provided. In particular, an effective amount of a sulphated polysaccharide,...
7220409 Stabilization of immunoglobulins at low pH  
The present invention provides a method of stabilizing immunoglobulins in a solution having a pH below 4 by adding cereals or hydrolysed cereal products in an amount sufficient to prevent...